venBio Global Strategic Fund II L.P., 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 115,442 shares at $19.64 ($2.3M) on 2020-01-06, disclosed to the SEC on 2020-01-08.
Open-market sale of $2.3M AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.64 | 42,221 | $829K | 36.3% |
| 2 | $19.64 | 42,221 | $829K | 36.3% |
| 3 | $20.17 | 31,000 | $625K | 27.4% |
| Total | $19.78 avg | 115,442 | $2.3M | 100% |
| Filing → |
| CMPI | SELL | 2022-04-29 | $3.2M | — | Filing → |
| IMPL | BUY | 2021-04-29 | $6.8M | — | Filing → |
| AKRO | SELL | 2020-07-06 | $8.0M | — | Filing → |